TO IMPROVE NEUROENDOCRINE TUMOR DISEASE MANAGEMENT THROUGH INCREASED RESEARCH AND EDUCATIONAL OPPORTUNITIES
Reported officers (all unpaid)
No paid executives reported in 2024. NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY reported 14 unpaid officers and board members on its 990.
Revenue and expenses over time
NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY reported revenue and expenses across 2 filing years.
What Medical Research executives earn in New York
NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable medical research organization in New York earns a median of $165,152.
These are medical research sector-wide figures, not this organization's reported pay. Based on 101 organizations across 101 filings (2022 – 2024).
See full Medical Research pay data for New York →Common questions about NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY
What are NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY's revenue and expenses?
In 2024, NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY reported $1.2M in total revenue and $1.3M in total expenses on its IRS Form 990.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.